Article
Identification of a Novel PPAR Signature for Predicting Prognosis and Immune Microenvironment in Hepatocellular Carcinoma
2022-08-12
Abstract excerpt
<h4>Background: </h4> Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver, which the 5-year survival rate has not substantially improved in the past few decades. We aimed to explore the potential role of peroxisome proliferator activated receptors (PPARs) in HCC progression and diagnosis. Methods The clinical information and corresponding gene expression matrix of HCC patients were o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31f1c790-cff5-5d90-9baf-4eda3ceda76c
- DOI
- 10.21203/rs.3.rs-1943906/v1
